biological products / given site / drug product / drug-related products / disease management protocols / organized health-care systems / health systems / pharmaceutical preparations / drug products / chemicals / /
MedicalCondition
disease / /
MedicalTreatment
medication errors / /
Organization
P&T committee / U.S. Department of Health and Human Services / Food and Drug Administration / ASHP Council on Pharmacy Practice / Formulary System Position American Society of Health-System Pharmacists / Pharmacy and Therapeutics Committee / Council on Pharmacy Practice / ASHP Board of Directors / Institute for Safe Medication Practices / P&T / American Society for Clinical Pharmacology and Therapeutics / American Society of Consultant Pharmacists / American Nurses Association / ASHP House of Delegates / American Society of Health / Academy of Managed Care Pharmacy / /
Person
Pamela C. Hagan / James L. Besier / Timothy R. Lanese / Shelley Hoppe Schliesser / Michael A. Valentino / Tom W. Woller / Allen J. Vaida / John L. Woon / Lee C. Vermeulen / Jr. / Patrick M. Malone / Thomas L. Kurt / Candis M. Morello / Sabrina W. Cole / Curt W. Quap / David G. Bowyer / Raymond W. Hammond / Michele F. Shepherd / Jonalan Smith / Daniel T. Abazia / William E. Wade / Mirta Millares / Linda S. Tyler / Lilian M. Azzopardi / Kenneth R. Baker / Andrew L. Wilson / Philip Anderson / Brady / Rosario (Russ) J. Lazzaro / Steven Dzierba / Marissa Schlaifer / James A. Ponto / Eric T. Hola / Patricia Kienle / Margaret Chrymko / Joseph W. Cranston / Katharine Kiser / J. Lyle Bootman / J. Russell / /
Statement on the Pharmacy and Therapeutics Committee and the Formulary System